StockData
CollPlant Biotechnologies Ltd logo

CollPlant Biotechnologies Ltd (CLGN) stock

CLGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as OPHI
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 9/30
$3.96+0.06 (+1.54%)

Close on Nov 11, 2026Market cap –P/E –Yield –

CollPlant Biotechnologies cash

Cash and short-term investments held at the end of each period.

CollPlant Biotechnologies's cash was $2.56M at Jun 30, 2026. For fiscal 2025 it was $5.59M, down 53.1% from the year before. The highest annual figure on record is $29.86M in fiscal 2022.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.59M-53.1%
FY2024Dec 31, 2024$11.91M-55.4%
FY2023Dec 31, 2023$26.67M-10.7%
FY2022Dec 31, 2022$29.86M+123.3%
FY2021Dec 31, 2021$13.37M+279.3%
FY2020Dec 31, 2020$3.53M-7.0%
FY2019Dec 31, 2019$3.79M-33.1%
FY2018Dec 31, 2018$5.66M+7.2%
FY2017Dec 31, 2017$5.28M+299.1%
FY2016Dec 31, 2016$1.32M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.56M-86.5%
Q4 FY2025Dec 31, 2025$5.59M-79.0%
Q2 FY2025Jun 30, 2025$11.43M-48.7%
Q4 FY2024Dec 31, 2024$11.91M-60.1%
Q2 FY2024Jun 30, 2024$18.92M-47.9%
Q4 FY2023Dec 31, 2023$26.67M+99.4%
Q2 FY2023Jun 30, 2023$22.28M+26.1%
Q4 FY2022Dec 31, 2022$29.86M+747.0%
Q2 FY2022Jun 30, 2022$36.29M+842.4%
Q4 FY2021Dec 31, 2021$13.37M+252.8%
Q2 FY2021Jun 30, 2021$17.68M+823.5%
Q4 FY2020Dec 31, 2020$3.53M-37.7%
Q2 FY2020Jun 30, 2020$3.85M+50.1%
Q4 FY2019Dec 31, 2019$3.79M-28.3%
Q2 FY2019Jun 30, 2019$1.91M+44.6%
Q4 FY2018Dec 31, 2018$5.66M–
Q2 FY2018Jun 30, 2018$2.57M–
Q4 FY2017Dec 31, 2017$5.28M–
Q4 FY2016Dec 31, 2016$1.32M–

More CollPlant Biotechnologies figures

See a number that looks wrong?